Unraveling the Impact of 177Lu-PSMA Radioligand Therapy on Renal Impairment: Distinguishing Causation from Correlation

被引：0
|
作者：
Kumar, Aravid S. Ravi [1 ]
Hofman, Michael S. [1 ]
机构：
[1] Univ Melbourne, Peter MacCallum Ctr Melbourne, Prostate Canc Theranost & Imaging Ctr Excellence, Mol Imaging & Therapeut Nucl Med Canc Imaging, Melbourne, Vic, Australia
来源：
JOURNAL OF NUCLEAR MEDICINE | 2024年 / 65卷 / 01期
基金：
澳大利亚国家健康与医学研究理事会;
关键词：
SAFETY;
D O I：
10.2967/jnumed.123.266638
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
引用
收藏
页码：85 / 86
页数：2
相关论文
共 50 条
  • [1] 177Lu-PSMA Radioligand Therapy for Prostate Cancer
    Fendler, Wolfgang P.
    Rahbar, Kambiz
    Herrmann, Ken
    Kratochwil, Clemens
    Eiber, Matthias
    JOURNAL OF NUCLEAR MEDICINE, 2017, 58 (08) : 1196 - 1200
  • [2] Long-Term Nephrotoxicity of 177Lu-PSMA Radioligand Therapy
    Steinhelfer, Lisa
    Lunger, Lukas
    Cala, Lisena
    Pfob, Christian H.
    Lapa, Constantin
    Hartrampf, Philipp E.
    Buck, Andreas K.
    Schaefer, Hannah
    Schmaderer, Christoph
    Tauber, Robert
    Brosch-Lenz, Julia
    Haller, Bernhard
    Meissner, Valentin H.
    Knorr, Karina
    Weber, Wolfgang A.
    Eiber, Matthias
    JOURNAL OF NUCLEAR MEDICINE, 2024, 65 (01) : 79 - 84
  • [3] PSMA-Negative Lesion Progression Under 177Lu-PSMA Radioligand Therapy
    Murthy, Vishnu
    Allen-Auerbach, Martin
    Lam, Richard
    Owen, Dawn
    Czernin, Johannes
    Calais, Jeremie
    JOURNAL OF NUCLEAR MEDICINE, 2023, 64 (09) : 1502 - 1503
  • [4] Rapid Tumor Washout of 177Lu-PSMA Radioligand in Renal Cell Carcinoma
    Zhang, Jingjing
    Schuchardt, Christiane
    Chen, Xiaoyuan
    Baum, Richard P.
    CLINICAL NUCLEAR MEDICINE, 2023, 48 (08) : 732 - 734
  • [5] Radiation levels outside a patient undergoing 177Lu-PSMA radioligand therapy
    Li, Huan
    Liu, Haikuan
    Zhang, Weiyuan
    Lin, Xin
    Li, Zhiling
    Zhuo, Weihai
    JOURNAL OF RADIOLOGICAL PROTECTION, 2024, 44 (02)
  • [6] 177Lu-PSMA radioligand therapy for isolated bilateral adrenal metastases from prostate cancer
    Perrone, Elisabetta
    Ghai, Kriti
    Eismant, Aleksandr
    Konz, Kornelia
    Baum, Richard P.
    ACTA ONCOLOGICA, 2024, 63 : 557 - 562
  • [7] Assessing Response to 177Lu-PSMA Radioligand Therapy Using Modified PSMA PET Progression Criteria
    Michalski, Kerstin
    Klein, Claudius
    Brueggemann, Tonio
    Meyer, Philipp T.
    Jilg, Cordula Annette
    Ruf, Juri
    JOURNAL OF NUCLEAR MEDICINE, 2021, 62 (12) : 1741 - 1746
  • [8] Pre- or Post-Chemotherapy: Effect of 177Lu-PSMA Radioligand Therapy on PSMA Expression
    Yadav, Surekha
    Heath, Courtney Lawhn
    Juarez, Roxanna
    De Kouchkovsky, Ivan
    Aggarwal, Rahul
    Hope, Thomas
    JOURNAL OF NUCLEAR MEDICINE, 2024, 65
  • [9] On the Quantitative Accuracy of xSPECT Quant Based Renal Uptake Determination for Internal Dosimetry in 177Lu-PSMA Radioligand Therapy
    Tran-Gia, Johannes
    Neumayer, Hashan
    Lassmann, Michael
    JOURNAL OF NUCLEAR MEDICINE, 2018, 59
  • [10] 177Lu-PSMA Radioligand Therapy for Prostate Cancer (vol 58, pg 1196, 2017)
    Fendler
    JOURNAL OF NUCLEAR MEDICINE, 2018, 59 (02) : 346 - 346
12345